| Literature DB >> 12452820 |
Abstract
A 46-year-old-man received high dose chemotherapy and an autologous stem-cell transplant for multiple plasmacytoma. He had a prolonged period of pancytopenia post-transplantation, which was thought to be due to a suboptimal dose of transplanted stem cells in combination with the effects of interferon therapy and an altered bone marrow microenvironment. Twenty-eight months after the transplant he was found to be hyperthyroid. Anti-thyroid therapy has led to a sustained improvement in his pancytopenia.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12452820 DOI： 10.1046/j.1365-2257.2002.00460.x
Source DB: PubMed Journal: Clin Lab Haematol ISSN： 0141-9854